# Bio Green Med (BGMS) — Earnings

BGMS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/bgms/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.98 |
| EPS estimate | −$72.00 |
| EPS surprise | +98.64% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $25,000.00 |
| Reported | Aug 13, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1130166/000164117225023648/form10-q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 13, 2025 | −$72.00 | −$0.98 | 98.64% | $25,000.00 | — |
| Q1 2025 | May 14, 2025 | −$69.60 | $0.00 | 100.00% | $25,000.00 | — |
| Q4 2024 | Apr 2, 2025 | −$69.60 | −$79.20 | -13.79% | $10,000.00 | $10,000.00 |
| Q3 2024 | Nov 12, 2024 | −$129.60 | −$43.20 | 66.67% | $10,000.00 | $10,000.00 |
| Q2 2024 | Aug 14, 2024 | −$344.40 | −$172.80 | 49.83% | $30,000.00 | $4,000.00 |
| Q1 2024 | May 14, 2024 | −$1,138.80 | −$544.80 | 52.16% | — | $29,000.00 |
| Q4 2023 | Mar 19, 2024 | −$1,414.40 | −$1,495.20 | -5.71% | — | $31,000.00 |
| Q3 2023 | Nov 13, 2023 | −$1,308.00 | −$1,764.00 | -34.86% | — | $16,000.00 |
| Q2 2023 | Aug 9, 2023 | −$1,812.00 | −$1,584.00 | 12.58% | — | $373,000.00 |
| Q1 2023 | May 11, 2023 | −$2,388.00 | −$1,692.00 | 29.15% | — | — |
| Q4 2022 | Mar 6, 2023 | −$1,737.00 | −$2,160.00 | -24.35% | — | — |
| Q3 2022 | Nov 9, 2022 | −$1,836.00 | −$1,512.00 | 17.65% | — | — |
| Q2 2022 | Aug 10, 2022 | −$1,935.00 | −$1,656.00 | 14.42% | — | — |
| Q1 2022 | May 11, 2022 | −$2,466.00 | −$1,512.00 | 38.69% | — | — |
| Q4 2021 | Mar 28, 2022 | −$2,466.00 | −$1,944.00 | 21.17% | — | — |
| Q3 2021 | Nov 10, 2021 | −$2,520.00 | −$1,944.00 | 22.86% | — | — |
| Q2 2021 | Aug 11, 2021 | −$1,836.00 | −$2,016.00 | -9.80% | — | — |
| Q1 2021 | May 12, 2021 | −$1,752.00 | −$1,800.00 | -2.74% | — | — |
| Q4 2020 | Feb 25, 2021 | −$1,908.00 | −$4,824.00 | -152.83% | — | — |
| Q3 2020 | Nov 12, 2020 | −$1,980.00 | −$1,692.00 | 14.55% | — | — |

## Frequently Asked Questions

### When did Bio Green Med (BGMS) last report earnings?

Bio Green Med last reported on Aug 13, 2025, covering fiscal Q2 2025.

### Did BGMS beat earnings estimates?

Yes. Bio Green Med reported EPS of −$0.98 for Q2 2025 against a −$72.00 estimate — a 98.64% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).